New medical technology startups identified in February 2012

A small list of new medical technology companies were identified in February 2012.  While the number of companies ID'd is down from past months, it is only partially attributable to what one might call a "slowdown" in startup formation. February is often a "slower" month that is eclipsed by December and January activity.

Below is a list of the technologies under development at companies identified and included in MedMarket Diligence's Medtech Startups Database:

  • Regenerative bandage for the eye that absorbs, dissolves and rapidly heals wounds.
  • undisclosed medical technology (stealth company)
  • Cryoablation for chest and airway applications.
  • Cervical and lumbar prosthetic disc replacement devices.
  • Regenerative medicine based on stromal vascular fraction derived from adult adipose tissue.

Complete details on the companies identified in February 2012, as well as all startup companies identified over the past few years, are available in the Medtech Startups Database.

2 thoughts on “New medical technology startups identified in February 2012”

  1. Sickle cell is an inherited disease resulting from a person receiving genes from both parents for an abnormally formed hemoglobin, which distorts the shape of the red blood cell and causes them to not flow normally in the blood stream. (People who receive a normal hemoglobin gene from one parent and a sickle cell gene from the other parent have what is called “sickle cell trait”, resulting in few complications for most patients.)
    Because sickle cell is an inherited disease, it can only be “cured”, in principle, by replacing the defective genes. Medical science is working aggressively in this direction, but this remains a big technology hurdle, given the complexity needed to achieve it. For the time being, treatments for sickle cell can at best be accomplished with bone marrow transplant (creating a “factory” in bone marrow to produce red blood cells with normal hemoglobin). Otherwise, a wide variety of options are available to help sickle cell patients deal with the complications.

Leave a Reply